Pro-PG Distributed and Promoted Products

Unlicensed Products 

Pro Pharmaceuticals Group has on hand in Melbourne a number of Unlicensed Medicines sourced from around the world that we supply via the Special Access Scheme, Authorised Prescriber or S19a pathway. Due to TGA advertising rules we are unable to list these products on our website however we can be contacted by Hospitals for a request of products.

 

These products are all stored in temperature controlled facilities and we distribute these directly to Hospitals and Retail Pharmacies via our 3rd party logistics provider. 

Current S19A Distributing/Sponsor:

These products are NOT registered in Australia and supply is granted under an exemption by the Therapeutic Goods Administration (TGA) under Section 19A of the Therapeutic Goods Act, 1989 until the below dates. 

  • IMIPRAMINE LEADING (imipramine) 25mg Tablets pack of 100 (S19A Sponsor: Pro Pharmaceuticals Group) - supply granted until  30/6/2021

  • CARBIMAZOLE DAWA 5mg [100] TAB (S19A Sponsor: Seed Pharma) - supply granted until 30/5/2021

  • IMIPRAMINE LEADING (imipramine) 10mg Tablets pack of 100 (S19A Sponsor: Pro Pharmaceuticals Group) - supply granted until 31/8/2021

TGA Registered Products

Pro Pharmaceuticals Group is the Australian exclusive distributor for the below products available via National wholesaler distributors Symbion (EBOS), Central Healthcare Services (Sigma) and Clifford Hallam Healthcare (CH2). 

  

  • MEDITAB IRINOTECAN irinotecan hydrochloride trihydrate 100 mg / 5 mL injection vial (TGA Sponsor: Cipla Australia) 

  • BLEOMYCIN 15K bleomycin sulfate 15000 IU powder for injection vial (TGA Sponsor: Cipla Australia)

  • ENTAC 0.5mg (Entecavir as monohydrate) 0.5 mg film coated tablets (TGA Sponsor: Cipla Australia)

  • ENTAC 1mg (Entecavir as monohydrate) 1 mg film coated tablets (TGA Sponsor: Cipla Australia)

Please contact us for additional Information email: info@propg.com.au 

 

S19A Carbimazole